Swiss National Bank’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Hold |
200,100
| – | – | ﹤0.01% | 1710 |
|
|
2025
Q1 | $1.49M | Sell |
200,100
-3,000
| -1% | -$22.3K | ﹤0.01% | 1937 |
|
|
2024
Q4 | $1.22M | Buy |
+203,100
| New | +$1.22M | ﹤0.01% | 2113 |
|
|
2024
Q2 | – | Sell |
-199,600
| Closed | -$641K | – | 2460 |
|
|
2024
Q1 | $641K | Hold |
199,600
| – | – | ﹤0.01% | 2401 |
|
|
2023
Q4 | $978K | Sell |
199,600
-22,500
| -10% | -$110K | ﹤0.01% | 2251 |
|
|
2023
Q3 | $1.21M | Buy |
222,100
+3,800
| +2% | +$20.7K | ﹤0.01% | 2131 |
|
|
2023
Q2 | $1.46M | Buy |
218,300
+2,300
| +1% | +$15.4K | ﹤0.01% | 2087 |
|
|
2023
Q1 | $1.91M | Sell |
216,000
-25,500
| -11% | -$225K | ﹤0.01% | 1868 |
|
|
2022
Q4 | $1.85M | Buy |
241,500
+5,400
| +2% | +$41.3K | ﹤0.01% | 1945 |
|
|
2022
Q3 | $1.68M | Buy |
236,100
+2,600
| +1% | +$18.5K | ﹤0.01% | 1993 |
|
|
2022
Q2 | $1.89M | Buy |
233,500
+16,600
| +8% | +$134K | ﹤0.01% | 1958 |
|
|
2022
Q1 | $3.01M | Buy |
216,900
+15,300
| +8% | +$212K | ﹤0.01% | 1780 |
|
|
2021
Q4 | $5.66M | Hold |
201,600
| – | – | ﹤0.01% | 1379 |
|
|
2021
Q3 | $6.85M | Buy |
201,600
+2,100
| +1% | +$71.4K | ﹤0.01% | 1239 |
|
|
2021
Q2 | $8.15M | Sell |
199,500
-3,600
| -2% | -$147K | 0.01% | 1149 |
|
|
2021
Q1 | $8.18M | Buy |
203,100
+3,500
| +2% | +$141K | 0.01% | 1116 |
|
|
2020
Q4 | $11.8M | Buy |
199,600
+27,000
| +16% | +$1.6M | 0.01% | 843 |
|
|
2020
Q3 | $8.39M | Buy |
172,600
+3,400
| +2% | +$165K | 0.01% | 885 |
|
|
2020
Q2 | $8.19M | Buy |
+169,200
| New | +$8.19M | 0.01% | 871 |
|